Galactosamine induced liver injury.
D000596:Amino Acids / Q000378:metabolism; D000818:Animals; D056486:Chemical and Drug Induced Liver Injury / Q000201:enzymology / Q000209:etiology* / Q000473:pathology; D004195:Disease Models, Animal; D004305:Dose-Response Relationship, Drug; D005399:Fishes; D005688:Galactosamine / Q000008:administration & dosage / Q000009:adverse effects* / Q000037:antagonists & inhibitors / Q000378:metabolism; D005943:Gluconeogenesis; D006168:Guinea Pigs; D000882:Haplorhini; D006801:Humans; D008099:Liver / Q000187:drug effects* / Q000378:metabolism / Q000473:pathology; D011506:Proteins / Q000378:metabolism; D012313:RNA / Q000096:biosynthesis; D011817:Rabbits; D051381:Rats; D014500:Uracil Nucleotides / Q000378:metabolism; D014529:Uridine / Q000627:therapeutic use
D000596:Amino Acids; D011506:Proteins; D014500:Uracil Nucleotides; D012313:RNA; D005688:Galactosamine; D014529:Uridine